Risk factors for adverse events related to polypectomy in the English Bowel Cancer Screening Programme

被引:160
|
作者
Rutter, Matthew D. [1 ,5 ]
Nickerson, Claire [2 ]
Rees, Colin J. [3 ,5 ]
Patnick, Julietta [2 ]
Blanks, Roger G. [4 ]
机构
[1] Univ Hosp North Tees, Stockton On Tees TS19 8PE, Cleveland, England
[2] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England
[3] South Tyneside NHS Fdn Trust, South Shields, England
[4] Univ Oxford, Canc Epidemiol Unit, Oxford, England
[5] Univ Durham, Durham, England
关键词
COLONOSCOPY; COMPLICATIONS; PERFORATION; EXPERIENCE; HEMORRHAGE; QUALITY; COLON;
D O I
10.1055/s-0033-1344987
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and study aims: The English National Health Service Bowel Cancer Screening Programme (NHSBCSP) is one of the world's largest organized screening programs. Minimizing adverse events is essential for any screening program. Study aims were to determine rates and to examine risk factors for adverse events. Patients and methods: Bleeding and perforations in NHSBCSP colonoscopies between August 2006 and January 2012 were examined. Logistic regression was used to examine risk factors for adverse events, including age, gender, polyp size, morphology, and location. For accurate attribution of adverse events, procedures with resection of only one polyp (single-polypectomy) were analyzed in detail. Results: 130831 colonoscopies (167208 polypectomies) were analyzed, including 30881 single-polypectomies. Overall bleeding rate was 0.65%, rate of bleeding requiring transfusion was 0.04% and perforation rate was 0.06%. Polypectomy increased bleeding risk 11.14-fold and perforation risk 2.97-fold. Cecal location (but not elsewhere in the proximal colon) and increasing polyp size were the two most important risk factors for bleeding and perforation. After adjustment for polyp size, the odds ratio (OR) relative to the distal colon for bleeding requiring transfusion after cecal snare polypectomy was 13.5 (95%CI 3.9-46.4) and for perforation after cecal nonpedunculated polypectomy it was 12.2 (95%CI 1.2-119.5). Conclusion: This is the largest study focusing on polyp-specific risk factors. We have confirmed that the greatest risk factor for both post-polypectomy bleeding and perforation is polyp size. This is the first demonstration of substantial and significantly increased risk for both noteworthy bleeding (requiring transfusion) and perforation from cecal polypectomy for a given polyp size, compared with elsewhere in the colon.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [41] Low Risk of Neoplasia and Intraprocedural Adverse Events in Gastric Hyperplastic Polypectomy
    Bar, Nir
    Kinaani, Fadi
    Sperber, Ami D.
    Amir-Barak, Hadar
    Dekel, Roy
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (10) : 851 - 855
  • [42] POST-IMAGING COLORECTAL CANCER IN THE ENGLISH NATIONAL HEALTH SERVICE BOWEL CANCER SCREENING PROGRAMME
    Derbyshire, Edmund
    Plumb, Andrew
    Nickerson, Claire
    Moores, Billie
    Wright, Suzanne
    Morris, Eva
    Valori, Roland
    Rutter, Matt
    GUT, 2019, 68 : A189 - A190
  • [43] Baseline risk factors associated with immune related adverse events and atezolizumab
    Madjar, Katrin
    Mohindra, Rajat
    Duran-Pacheco, Gonzalo
    Rasul, Rashad
    Essioux, Laurent
    Maiya, Vidya
    Chandler, G. Scott
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] The Downstaging of Colorectal Cancers By the English National Bowel Cancer Screening Programme - Data from the First Screening Centre
    Fogden, Edward N.
    Ellul, Pierre
    Rowlands, David
    Simpson, Clare
    McKaig, Brian
    Swarbrick, Edwin T.
    Veitch, Andrew
    GASTROENTEROLOGY, 2009, 136 (05) : A770 - A770
  • [45] Slipping through the bowel cancer screening programme
    Hallifax, R.
    Lacey, M.
    Bevis, P.
    Borley, N. R.
    Brooklyn, T.
    Wheeler, J. M. D.
    COLORECTAL DISEASE, 2012, 14 (07) : 844 - 847
  • [46] NHS BOWEL CANCER SCREENING PROGRAMME IN ENGLAND
    Coleman, L.
    Fretwell, I.
    GUT, 2011, 60 : A250 - A250
  • [47] Risk factors associated with immune-related severe adverse events in patients with cancer: A scoping review
    Su, Zhenzhen
    Zhang, Liyan
    Lian, Xuemin
    Wang, Yixuan
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2025, 12
  • [48] Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam
    Eichstadt, L. R.
    Moore, G. E.
    Childress, M. O.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (04) : 1346 - 1353
  • [49] Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
    Changhwan Sung
    Jinhyeon An
    Soohyeon Lee
    Jaesoon Park
    Kang Seon Lee
    Il-Hwan Kim
    Ji-Youn Han
    Yeon Hee Park
    Jee Hyun Kim
    Eun Joo Kang
    Min Hee Hong
    Tae-Yong Kim
    Jae Cheol Lee
    Jae Lyun Lee
    Shinkyo Yoon
    Chang-Min Choi
    Dae Ho Lee
    Changhoon Yoo
    Sang-We Kim
    Jae Ho Jeong
    Seyoung Seo
    Sun Young Kim
    Sun-Young Kong
    Jung Kyoon Choi
    Sook Ryun Park
    Nature Cancer, 2023, 4 : 844 - 859
  • [50] Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
    Sung, Changhwan
    An, Jinhyeon
    Lee, Soohyeon
    Park, Jaesoon
    Lee, Kang Seon
    Kim, Il-Hwan
    Han, Ji-Youn
    Park, Yeon Hee
    Kim, Jee Hyun
    Kang, Eun Joo
    Hong, Min Hee
    Kim, Tae-Yong
    Lee, Jae Cheol
    Lee, Jae Lyun
    Yoon, Shinkyo
    Choi, Chang-Min
    Lee, Dae Ho
    Yoo, Changhoon
    Kim, Sang-We
    Jeong, Jae Ho
    Seo, Seyoung
    Kim, Sun Young
    Kong, Sun-Young
    Choi, Jung Kyoon
    Park, Sook Ryun
    NATURE CANCER, 2023, 4 (06) : 844 - +